Brief: Aspira Women’s Health Supports Centers for Medicare & Medicaid Services Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch
09/11/2023 13:18
Nov 9 (Reuters) - Aspira Women's Health Inc AWH.O :
* ASPIRA WOMEN’S HEALTH SUPPORTS CENTERS FOR MEDICARE &
MEDICAID
SERVICES (CMS) PROPOSED RULE TO CROSSWALK MEDICARE REIMBURSEMENT
RATE FOR OVAWATCH
* ASPIRA WOMEN'S HEALTH INC - PROPOSED RULE WOULD ALLOW FOR
OVAWATCH(SM) TO BE REIMBURSED AT SAME RATE AS OVA1(®) AT $897
PER TEST
Source text for Eikon: ID:nGNX93W4r5
Further company coverage: AWH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance